Learn / VRDN
NASDAQ: VRDN
Viridian Therapeutics, Inc.\DE (VRDN) stock, explained like you're 5
Viridian Therapeutics, Inc.\DE trades on the Nasdaq under the ticker VRDN. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.
- Ticker
- VRDN
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 2.1 billion dollars
Is Viridian Therapeutics, Inc.\DE a small, medium or large cap company?
No. Viridian Therapeutics, Inc.\DE is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Viridian Therapeutics, Inc.\DE makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves VRDN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Viridian Therapeutics (VRDN) Stock May Look Stretched Against Its Sales Base (Yahoo Finance)
- VRDN Stock Jumps 6% After Hours As Viridian Wins First FDA Approval (Stocktwits)
- Viridian Therapeutics (NasdaqCM:VRDN) Aktienprognose & Analystenprognosen (Simply Wall Street)
- Viridian Therapeutics (VRDN) legal chief sells 14,212 shares (Stock Titan)
- Viridian Therapeutics (VRDN) slides 26.8% as investors digest Phase 3 REVEAL 1 data and reset expectations (Quiver Quantitative)
Follow VRDN in your daily brief
Each trading day at 5 PM ET we post what happened to Viridian Therapeutics, Inc.\DE and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow VRDN
Questions about Viridian Therapeutics, Inc.\DE stock
What does Viridian Therapeutics, Inc.\DE do?
Viridian Therapeutics, Inc.\DE trades on the Nasdaq under the ticker VRDN. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.
What is the ticker symbol for Viridian Therapeutics, Inc.\DE?
Viridian Therapeutics, Inc.\DE trades under the ticker VRDN on the Nasdaq.
What is Viridian Therapeutics, Inc.\DE's market cap?
Viridian Therapeutics, Inc.\DE is a mid cap stock with a market cap of about 2.1 billion dollars.
How does Viridian Therapeutics, Inc.\DE make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves VRDN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow VRDN stock every day?
Add VRDN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.